Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
January 05 2005 - 7:15AM
PR Newswire (US)
Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,
Inc. (NASDAQ:AMLN) will be presenting at the JPMorgan Healthcare
Conference on Monday, January 10, 2005 at 9:00 a.m. Pacific Time in
San Francisco, California. Ginger L. Graham, President and Chief
Executive Officer of Amylin Pharmaceuticals will be providing a
corporate overview, which will include a review of the company's
development programs. The company will also participate in a
webcast breakout session immediately following the presentation at
9:30 a.m. Pacific Time. Additionally, Amylin will be webcasting a
discussion with investors from a separate event being held in
conjunction with the JPMorgan conference at 7:00 p.m. Pacific Time
on Tuesday, January 11, 2005. The presentations and the breakout
session will be webcast separately, and recordings will be made
available following each event. The webcasts and the recordings
will be accessible through Amylin's corporate website, located at
http://www.amylin.com/. To access the live webcasts, please log on
to Amylin's site approximately fifteen minutes prior to the
presentation to register and download any necessary audio software.
Amylin Pharmaceuticals is committed to improving the lives of
people with diabetes and other metabolic diseases through the
discovery, development and commercialization of innovative,
cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Mark G. Foletta, Vice President of Finance and Chief
Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200
Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024